These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Purpuric drug eruption with leukocytoclastic vasculitis due to gefitinib. Uchimiya H, Higashi Y, Kawai K, Kanekura T. J Dermatol; 2010 Jun 15; 37(6):562-4. PubMed ID: 20536674 [No Abstract] [Full Text] [Related]
15. Purpuric vasculitis-like eruption in a patient sensitive to balsam of Peru. Bruynzeel DP, van den Hoogenband HM, Koedijk F. Contact Dermatitis; 1984 Oct 21; 11(4):207-9. PubMed ID: 6499422 [Abstract] [Full Text] [Related]
16. Purpuric drug eruption without leukocytoclastic vasculitis associated with vancomycin. Nakamura T, Wakiguchi H, Okazaki F, Asano N, Hoshii Y, Hasegawa S. Asian Pac J Allergy Immunol; 2020 Mar 21; 38(1):47-51. PubMed ID: 30447655 [Abstract] [Full Text] [Related]
18. Leukocytoclastic vasculitis with purpura and renal failure induced by the anti-epidermal growth factor receptor antibody panitumumab: a case report. Kamo H, Shinozaki E, Sugase T, Mizunuma N, Taniguchi S, Gotoh T, Chin K, Tanaka T, Koga K, Yamaguchi K. J Med Case Rep; 2019 Jan 16; 13(1):13. PubMed ID: 30646927 [Abstract] [Full Text] [Related]
19. [Urticarian vasculitis. A case report after sulfamethoxazoletriméthoprime ingestion]. Feiza BA, Samy F, Asma D, Rym B, Insaf M. Tunis Med; 2005 Nov 16; 83(11):714-6. PubMed ID: 16422373 [Abstract] [Full Text] [Related]